Nature Sourced. Neptune Perfected.
  • NEPT1.75-0.01 -0.57%
  • NTB.TO2.11+0.01 +0.48%

Press Releases

2014

Jim Hamilton Appointed President & CEO of Neptune -pdf on 21/11/2014
Neptune Completes Plant Ramp-Up
-pdf on 05/11/2014
Neptune and BlueOcean Sign Licensing Agreement
-pdf on 20/10/2014
Neptune Announces Normal Course Issuer Bid
-pdf on 15/10/2014
Neptune Announces Second Quarter Results – Shipments of NKO® Underway – pdf on 14/10/2014
Neptune to Hold Conference Call to Discuss Second Quarter Results -pdf on 8/10/2014
Neptune Reaches Annualized Production Capacity of 100 Metric Tons -pdf on 23/09/2014
Neptune to Present at Rodman & Renshaw Global Investment Conference – pdf on 3/09/2014
Neptune’s Production Ramp-up on Target – pdf on 14/08/2014
Neptune Announces First Quarter Results – pdf on 15/07/2014
Neptune to Hold Conference Call to Discuss First Quarter Results – pdf on 08/07/2014
Neptune Receives Composition Patent in Australia – pdf on 23/06/2014
Neptune Reports Results of Annual and Special Meeting – pdf on 19/06/2014
Neptune Sherbrooke Plant to Resume Production – Product Line Expanded – pdf on 13/06/2014
Neptune, Acasti and NeuroBioPharm Announce Litigation Regarding its Former Chief Executive Officer – pdf on 30/05/2014
Neptune, Acasti and NeuroBioPharm Announce Appointment of Interim CEO – pdf on 23/05/2014
Neptune Announces Fourth Quarter and Fiscal Year Results – pdf on 21/05/2014
NeuroBioPharm Announces Resignation of Chief Financial Officer – pdf on 20/05/2014
Neptune Announces Proposed Director Nominees for its Upcoming Annual General Meeting -pdf on 16/05/2014
Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year Results – pdf on 13/05/2014
Neptune Provides Update on Plant Operating Permits – pdf on 08/05/2014
Neptune Receives CSST Report – pdf on 08/05/2014
Neptune, Acasti and NeuroBioPharm Announce Resignation of Chief Executive Officer – pdf on 27/04/2014
Neptune and Enzymotec Conclude Final Patent Infringement Settlement and License Agreement – pdf on 27/04/2014
Neptune Obtains New US Patent Relating to Treatment of Alzheimer’s – pdf on 24/04/2014
Neptune Responds to Enzymotec’s Continuous Attempts to Shift Focus from ITC Investigation – pdf on 21/04/2014
Neptune Announces Closing of CAD$2.5 Million Private Placement – pdf on 04/04/2014
Neptune & Acasti Give Update on Patent Litigations with Enzymotec – pdf on 01/04/2014
Neptune Provides Update on Sherbrooke Plant – pdf on 27/03/2014
NeuroBioPharm Extends Life of Warrants and Provides Other Corporate Updates – pdf on 18/03/2014
Neptune Announces Closing of the Over-Allotment Option Associated with its Recently Completed Public Offering of Common Shares – pdf on 06/03/2014 Neptune Announces Closing of US$25.0 Million Underwritten Offering of Common Shares – pdf on 05/03/2014
Neptune Announces Pricing of US$25 million Offering of Common Shares – pdf on 28/02/2014
Neptune Announces Proposed Offering of Common Shares – pdf on 27/02/2014
Neptune Appoints John Moretz as Special Advisor and Nominee to its Board of Directors – pdf on 18/02/2014
Neptune and Acasti Provide Update on Patent Litigations with Enzymotec – pdf on 14/02/2014
Neptune Reports Third Quarter Results and Provides Update on Action Plan to Resume Operations – pdf on 14/01/2014
Neptune Receives New Food Raw Material Certification in China – pdf on 09/01/2014
Neptune to Hold Conference Call to Discuss Third Quarter Results – pdf on 07/01/2014http://neptunekrilloil.com/pdf/

2013

Neptune Appoints Jerald J. Wenker as Special Advisor and Nominee to Its Board of Directors – pdf on 19/12/2013
Neptune, Acasti and Enzymotec Sign Settlement Term Sheet Resulting in Stay of ITC Investigation for 30 Days – pdf on 18/12/2013
Neptune and Aker BioMarine Reach Patent Infringement Settlement And License Agreement – pdf on 17/12/2013
Neptune Participates in the Equity Financing of Acasti Pharma – pdf on 03/12/2013
Neptune Holds Annual Charity Poker Game to Benefit Vitamin Angels – pdf on 12/11/2013
Neptune Reaffirms its Patent Position – pdf on 12/11/2013
Neptune to Oppose CSST Statement – pdf on 08/11/2013
Reed V. Tuckson, M.D. Joins Neptune’s Board of Directors – pdf on 05/11/2013
Neptune Reports Second Quarter Results and Provides Update on Action Plan to Resume Operations – pdf on 15/10/2013
Neptune Receives $12.5 Million Loan Offer from Investissement Québec – pdf on 11/10/2013
Neptune to Hold Conference Call to Discuss Second Quarter Results – pdf on 10/10/2013
Neptune and Rimfrost Sign Krill Oil Manufacturing and Supply Agreement – pdf on 02/10/2013
Patent Infringement Settlements Reached Neptune Grants a Royalty Bearing License on its Patents – pdf on 02/10/2013
Neptune Receives Additional $5 million Insurance Payment – pdf on 26/08/2013
Neptune Awarded Canadian Composition of Matter Patent – pdf on 16/07/2013
First Quarter Results and Update on Action Plan – pdf on 15/07/2013
Neptune Announces Issuance of Shares – pdf on 12/07/2013
Neptune to Hold Conference Call to Discuss First Quarter Results – pdf on 09/07/2013
Neptune to Present at JMP Securities Healthcare Conference – pdf on 04/07/2013
Neptune Commences Reconstruction of Sherbrooke Plant – pdf on 28/05/2013
Neptune Reports Fiscal 2013 Results and Provides Update on Action Plan to Resume Operations – pdf on 23/05/2013
Neptune Responds to Aker’s Continued Attempts to Deflect Attention from its Sustained Patent Infringement – pdf on 16/05/2013
Class Action Lawsuit Against Neptune Dismissed – pdf on 16/05/2013
Neptune to Hold Conference Call – pdf on 09/05/2013
The U.S. International Trade Commission (ITC) Votes to Institute Patent Infringements Investigation based on Neptune & Acasti Complaint – pdf on 16/04/2013 Neptune Provides Update on European Patent Dispute and Maintains its International Patent Strategy – pdf on 11/04/2013
Neptune to Present at the Annual ROTH Conference – pdf on 14/03/2013
Neptune Obtains a Third U.S. Patent on Phospholipid Compositions, Further Bolstering Neptune’s Request for an ITC Investigation – pdf on 26/02/2013
Neptune Responds to Aker BioMarine’s Attempt to Shift the Focus from Neptune’s Major ITC Filing – pdf on 05/02/2013
Neptune files ITC Complaint against competitors Aker, Enzymotec, Rimfrost, Olympic and others – pdf on 31/01/2013
Neptune Obtains Allowance of Patent Specific to Krill Oil And Announces Management Reorganization – pdf on 24/01/2013
Neptune Reports Third Quarter Results and Confirms First Insurance Payment – pdf on 15/01/2013
Neptune to Hold Conference Call – details – pdf on 14/01/2013
Neptune to Hold Conference Call – pdf on 07/01/2013

2012

Royalty Prepayment Agreement with Acasti – pdf on 04/12/2012
Opposition of Aker’s Australian Patent – pdf on 27/11/2012
Action Plan Post Incident – pdf on 26/11/2012
Conference Call for Post Incident – pdf on 26/11/2012
Neptune is Actively Working on Action Plan – pdf on 16/11/2012
2012-11-12 Neptune Press Release – Explosion – pdf on 12/11/2012
2012-11-05 Poker tournament – pdf on 05/11/2012
Neptune Reports Second Quarter Results – pdf on 15/10/2012
Neptune Confirms Dividend Ratio for Partial Spin-Off of NeuroBioPharm Inc. – pdf on 04/10/2012
Neptune Dismisses Aker’s Inaccurate Allegations About Its New Patent – pdf on 03/10/2012
Neptune Files a Second Patent Infringement Suit Against Competitors Aker, Enzymotec, and Others – pdf on 02/10/2012
Neptune Secures Another U.S. Patent – pdf on 01/10/2012
Neptune Announces Pricing of US$30 million Offering of Common Shares – pdf on 25/09/2012
Neptune Announces Proposed Offering of Common Shares – pdf on 24/09/2012
Neptune Krill Oil Specifications Sheet – pdf on 20/09/2012
ECO Krill Oil Specifications Sheet – pdf on 20/09/2012
Neptune Reports Preliminary Revenues on Second Quarter – pdf on 11/09/2012
Neptune Announces Dividend-In-Kind and Record Date for Partial Spin-Off of NeuroBioPharm Inc. – pdf on 07/09/2012
Neptune’s Competitor Claims an Illusory Victory – pdf on 06/09/2012
Neptune & Acasti Reappoint The Howard Group as Investor Relations Consultant – pdf on 28/08/2012
Neptune Reports First Quarter Results – pdf on 16/07/2012
ASIAN Market Exceptional Growth Boosting Neptune’s Sales – pdf on 21/06/2012
Neptune’s Allowance of Continuation of ‘348 Patent Strengthens Its Position in the U.S. – pdf on 07/06/2012
Neptune Reports Preliminary Revenues on First Quarter – pdf on 05/06/2012
Neptune to Hold Conference Call – pdf on 30/05/2012
Neptune Reports Fiscal 2012 Results – pdf on 25/05/2012
Neptune’s Board of Director Welcomes Dr. Harlan Waksal – pdf on 23/05/2012
Neptune, the Only Krill Oil Manufacturer Certified as “Friend of the Sea” – pdf on 22/05/2012
Neptune Believes the Australian Patent Office Will Reconsider its Grant of Aker’s Australian Patent – pdf on 22/05/2012
Neptune Confirms its Pre-eminence in the Australian Market – pdf on 08/05/2012
NKO® Ambassador John Elway to Speak at SupplySide MarketPlace (NYC) and to Visit Neptune’s Booth – pdf on 03/05/2012
Neptune Appoints New IR firm for the US – pdf on 27/03/2012
Neptune Signs John Elway, NFL Hall-of-Famer, as Official Brand Ambassador – pdf on 27/03/2012
Neptune Technologies & Bioressources Investing Over $20M in Sherbrooke – pdf on 09/03/2012
Neptune Technologies & Bioressources investing over $20M in Sherbrooke – pdf on 09/03/2012
Neptune to Present at The 24th Annual Roth Conference – pdf on 06/03/2012
Neptune Must Again Rectify Competitor’s Misleading Statement – pdf on 01/03/2012
Neptune Premium Krill Oil, NKO® Enters the Mass Market with Jamieson Laboratories, the Largest Brand in Canada – pdf on 15/02/2012
Neptune Acquires Common Shares of Acasti Pharma – pdf on 13/02/2012
Neptune, Aker and Schiff Agree to Stay of Litigation during Patent Re-examination Proceedings – pdf on 02/02/2012
Neptune Reports Third Quarter Results – pdf on 17/01/2012
Neptune Pursues its IP Strategy with Continuation Applications – pdf on 12/01/2012
ERRATUM – Neptune To Hold Conference Call – pdf on 11/01/2012
Neptune To Hold Conference Call – pdf on 11/01/2012http://neptunekrilloil.com/pdf/

2011

Neptune Starts Phase-I Sherbrooke Plant Expansion – pdf on 12/12/2011
Neptune Reports Preliminary Revenues on Record Quarter – pdf on 01/12/2011
Neptune Technologies & Bioressources Common Shares Graduate to the TSX – pdf on 24/11/2011
Neptune reaffirms its confidence in its patent protection and the US prosecution process – pdf on 17/11/2011
Neptune Technologies & Bioressources Announces the Inssuance of an Additional Key US Patent – pdf on 16/11/2011
Neptune Receives TSX Conditional Approval – pdf on 27/10/2011
Neptune Reports Second Quarter Results – pdf on 13/10/2011
Neptune Launches Patent Infringement Litigation against Aker Biomarine ASA, Enzymotec Ltd., and Others – pdf on 06/10/2011
Neptune Technologies & Bioressources Obtains New Patent Directed to Compositions of Omega-3 Fatty Acid Phospholipids including Krill Oil – pdf on 05/10/2011 Neptune To Hold Conference Call – pdf on 04/10/2011
Neptune’s customer is awarded “Product of the Year 2011” in Denmark – pdf on 28/09/2011
Neptune subscirbes to Acasti Pharma’s rights offering – pdf on 19/09/2011
Neptune penetrates Asia by partnering with Chinese SKFC, the world’s largest fleet owner of fishing Vessels – pdf on 19/09/2011
Neptune Reports First Quarter Results – pdf on 16/08/2011
Neptune Technologies & Bioressources Confirms Dividend of Acasti Rights – pdf on 06/07/2011
Neptune Technologies & Bioressources Inc. welcomes Dr. Anthony Holler to its Board of Directors – pdf on 05/07/2011
Neptune Secures and Increases US Food, Drug, Mass and Club Distribution – pdf on 22/06/2011
Neptune Stronger in Asia by Penetrating the Indian Market – pdf on 06/06/2011
Neptune Reports Fiscal 2011 Results – pdf on 30/05/2011
Neptune Technologies & Bioressources Closes Oversubscribed Private Placement Financing – pdf on 13/05/2011
Neptune Technologies & Bioressources Environmental Responsibility and Business Conduct Acknowledged by NSF International – pdf on 09/05/2011
Neptune Technologies & Bioressources Secures an additional $2.865M – pdf on 20/04/2011
Neptune Technologies & Bioressources Announces a Private Placement Financing of Approximately $10 Million USD – pdf on 19/04/2011
Neptune is Nominated as a Finalist for the Nutraceutical & Business Technology Awards 2011 and Prolongs US IR Agreement – pdf on 14/04/2011
Bayer Healthcare’s Artic Wonder Market Test Succeeds with Neptune Krill Oil Leading to US National Launch – pdf on 08/04/2011
Neptune Technologies & Bioressources Inc. subsidiary Acasti Pharma Inc. Shares to Trade on the TSX-Venture on March 31st – pdf on 30/03/2011
Neptune Reports on Preliminary 2011 Year End Results – pdf on 22/03/2011
Neptune Technologies & Bioressources Inc. to Present at the Roth OC Growth Stock Conference – pdf on 28/02/2011
Neptune Technologies & Bioressources Inc. Reports Net Profit for the Third Quarter – pdf on 13/01/2011
Neptune Technologies & Bioressources Inc. to Host Management Discussion Teleconference at 9:00 a.m. on January 14th – pdf on 12/01/2011http://neptunekrilloil.com/pdf/